Progenics Pharmaceuticals Inc
Pharmaceutical company · New York, United States
Progenics Pharmaceuticals Inc is a pharmaceutical company headquartered in New York, United States. It has received 44 US government small-business research awards (SBIR/STTR) from health agencies, $33 million in total, most recently in 2007. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2013.
Progenics Pharmaceuticals at a glance
What does Progenics Pharmaceuticals do?
US government research funding
44 SBIR/STTR small-business research awards from US health agencies, $32.8 million in total (1990 to 2007).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $12.9 million sold (2013).
Frequently asked questions about Progenics Pharmaceuticals
Where is Progenics Pharmaceuticals headquartered?
Progenics Pharmaceuticals Inc is headquartered in New York, United States.
What does Progenics Pharmaceuticals do?
Progenics Pharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
- SELLAS Life Sciences Group, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.